moxifloxacin has been researched along with amg531 in 3 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (amg531) | Trials (amg531) | Recent Studies (post-2010) (amg531) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 713 | 94 | 607 |
| Protein | Taxonomy | moxifloxacin (IC50) | amg531 (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 8.27 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.6605 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Kumari, D; Perveen, S; Sharma, R; Singh, K | 1 |
| Bowen, C; Jenkins, JM; Matthys, G; McGuire, S; Park, JW; Peng, B; Williams, D; Wire, MB; Zhang, J | 1 |
1 review(s) available for moxifloxacin and amg531
| Article | Year |
|---|---|
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance.
Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin | 2022 |
1 trial(s) available for moxifloxacin and amg531
| Article | Year |
|---|---|
Eltrombopag does not affect cardiac repolarization: results from a definitive QTc study in healthy subjects.
Topics: Adolescent; Adult; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Benzoates; Dose-Response Relationship, Drug; Electrocardiography; Epidemiologic Methods; Female; Fluoroquinolones; Heart Rate; Humans; Hydrazines; Male; Middle Aged; Moxifloxacin; Pyrazoles; Quinolines; Treatment Outcome; Young Adult | 2010 |
1 other study(ies) available for moxifloxacin and amg531
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |